Skip to main content

SB 5452

In Committee

Senate

Psychiatric pharmacists

Allowing board-certified psychiatric pharmacists to be licensed as agency-affiliated counselors.

This status may be delayed. See Action History below for the latest updates.

How does a bill become law?
  1. Introduced: The bill is filed and assigned a number.
  2. Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
  3. Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
  4. Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
  5. Governor: The Governor reviews the bill and decides whether to sign or veto it.
  6. Signed: The bill has been signed into law.
Introduced: January 22, 2025
Last Action: January 12, 2026
Status: S Health & Long-

AI Analysis

This analysis was generated by AI and may contain errors. It is not legal advice. Always refer to the official bill text for authoritative information.
People & CommunitiesPeople-leaningCorporate & Wealthy Interests

This bill allows board-certified psychiatric pharmacists to become licensed as agency affiliated counselors in Washington State, provided they meet specific education and experience requirements. It also updates licensing rules to include psychiatric pharmacists in the pool of eligible candidates while preserving pathways for existing mental health professionals.

  • Allows board-certified psychiatric pharmacists to qualify for a licensed agency affiliated counselor credential if they hold an advanced degree in health care (e.g., PharmD), complete required coursework, and have at least two years of experience in behavioral health care.
  • Expands the definition of acceptable experience and education for licensed agency affiliated counselors to include psychiatric pharmacists, in addition to traditional counseling or social science degrees.
  • Requires the Department of Health to define specific coursework requirements for counseling or health care credentials through rulemaking.
  • Establishes a 'legacy provision' allowing current or former mental health professionals with prior waivers or experience to qualify under older standards if they apply by July 1, 2027.
  • Maintains existing application, fee, and documentation requirements (e.g., proof of employment or internship status) for all agency affiliated counselor credentials.

Who is affected

  • Board-certified psychiatric pharmacistsBoard-certified psychiatric pharmacists who meet the experience and education requirements can now apply for a licensed agency affiliated counselor credential without needing a traditional counseling degree, enabling them to provide mental health counseling services in agency settings.
  • Mental health agenciesMental health agencies (e.g., community mental health centers, hospitals, behavioral health organizations) can now employ psychiatric pharmacists as licensed agency affiliated counselors, expanding their ability to provide integrated mental health and medication management services.
  • Residents receiving mental health servicesIndividuals seeking mental health services may gain access to counselors with specialized training in psychiatric medications, improving care coordination for people with complex mental health and medication needs.
  • Existing agency affiliated counselorsExisting licensed or certified agency affiliated counselors who applied before July 1, 2027, can use prior experience and credentials to qualify under a 'legacy provision' without needing to meet new coursework requirements.
Model: Intel/Qwen3-Coder-Next-int4-AutoRoundGenerated: Mar 19, 2026 at 8:58 PM

Pro/Con Analysis

Stronger case for benefits

Potential Benefits (5)
  • Allowing board-certified psychiatric pharmacists to become licensed agency affiliated counselors improves care coordination for individuals with serious mental illness by integrating medication management expertise with counseling services—especially valuable in rural or underserved areas where psychiatrists are scarce and patients often face fragmented care.

    HealthcarePeopleRef: Sec. 1, subsection (4)(b)
  • Expanding the eligible pool of licensed counselors to include psychiatric pharmacists helps alleviate workforce shortages in mental health agencies, particularly community mental health centers and hospitals that struggle to recruit and retain licensed counselors—especially in Eastern Washington and rural regions.

    Business & EmploymentPeopleRef: Sec. 1, subsection (4)(b)
  • The legacy provision preserves access to licensure for experienced mental health workers who obtained waivers before 1986 or 2001—many of whom are older, low-income, or from historically marginalized communities—preventing abrupt exclusion from practice and preserving continuity of care for long-term patients.

    Rights & LibertiesPeopleRef: Sec. 1, subsection (6)(a)(ii)-(iii)
  • Integrating pharmacists with behavioral health experience into counseling roles may reduce emergency psychiatric admissions and hospitalizations by enabling earlier, more holistic interventions—particularly for patients with dual diagnosis or treatment-resistant conditions.

    Public SafetyPeopleRef: Sec. 1, subsection (4)(b)
  • The July 1, 2027 deadline for legacy applicants provides a transition window that allows agencies to gradually integrate new providers while maintaining continuity of care—though it may benefit larger, better-resourced agencies more than small rural clinics with limited HR capacity.

    HealthcareLean peopleRef: Sec. 1, subsection (6)(c)
Potential Concerns (4)
  • Expanding eligibility for licensed agency affiliated counselor credentials to include psychiatric pharmacists without requiring a counseling-specific degree or supervised clinical training in psychotherapy may dilute the scope of practice and raise concerns about competency in evidence-based mental health counseling techniques, potentially increasing risk of misdiagnosis or inappropriate therapeutic interventions in community settings.

    Public SafetyRef: Sec. 1, subsection (4)(b)
  • The legacy provision requiring applications by July 1, 2027, creates a time-limited administrative burden on the Department of Health and local agencies to process applications, verify historical waivers, and verify prior experience—costs that fall disproportionately on publicly funded behavioral health agencies with limited staff capacity.

    Local GovernmentPeopleRef: Sec. 1, subsection (6)(c)
  • While psychiatric pharmacists bring medication expertise, they may lack formal training in psychotherapy modalities, differential diagnosis of complex mental illness, trauma-informed care, or crisis intervention—core competencies expected of licensed counselors—potentially reducing care quality for patients with severe or complex conditions unless supervision is robust.

    HealthcareLean peopleRef: Sec. 1, subsection (4)(b)
  • Delegating coursework requirements to department rulemaking without legislative specification creates uncertainty for applicants and training institutions, potentially delaying credentialing and fragmenting educational pathways across regions or agencies.

    EducationRef: Sec. 1, subsection (5)

Who Is Most Affected

Board-certified psychiatric pharmacistsMixed Impact

Board-certified psychiatric pharmacists with behavioral health experience gain a new career pathway and expanded scope of practice, enabling them to provide integrated mental health services—especially valuable in shortage areas. However, they must meet new coursework and supervision standards, and may face role ambiguity without traditional counseling training.

Mental health agenciesPositive Impact

Mental health agencies gain flexibility to hire providers with dual expertise in medication and counseling, improving service integration and potentially reducing staff turnover. But they must also ensure proper supervision, liability coverage, and compliance with evolving credentialing rules—costs that may strain small or underfunded agencies.

Residents receiving mental health servicesPositive Impact

Patients—especially those with complex mental illness, substance use disorders, or dual diagnosis—may benefit from more coordinated, holistic care. However, those in rural or under-resourced areas may see the greatest gains, while high-acuity patients could face risks if pharmacists lack sufficient psychotherapy training.

Existing agency affiliated counselorsMixed Impact

Existing counselors and social workers may benefit from reduced competition for certain roles, but could face increased pressure to supervise or collaborate with pharmacists in new roles—potentially expanding team-based care or, in under-resourced settings, diluting the counseling role without adequate support.

State and local government agenciesMixed Impact

The Department of Health gains expanded regulatory responsibility, including rulemaking for coursework and verification of legacy waivers. This increases administrative burden but also aligns with broader state goals of workforce expansion and integrated care—though small agencies may struggle to meet new requirements.

Sponsors

Senator Slatter(Democrat)District 48Primary
Senator Nobles(Democrat)District 28Secondary